ArticleInternational journal of pharmaceutics: X2026
Development of hyaluronic acid-based nanocomposite eye drops: A synergistic platform for enhanced ocular delivery of acetazolamide.
Giovanni Falcone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.